Well it looks like Trump is finally going to reign in out of control drug prices and end rebates to stop drug companies buying their way on formularies! The rebates are gone as of January 1, 2020. Can you say layoffs? https://endpts.com/executive-order-under-construction-to-peg-us-drug-prices-to-lowest-prices-abroad-trump-says/
Lundbeck doesn’t offer rebates on its rare disease products. Just one more reason you psych lunatics are an inferior species that will soon die off.
Even so, I would bet we sell it a hell of a lot cheaper somewhere else in the world than we do here. If another country can get it at the bargain price of $100,000 (ridiculous amount!) a year or less, then that’s what we will have to price it in the U.S. Read the article. One way or another, all U.S. Pharmaceutical companies will have to match the price at the lowest price found in other countries. It will be a blow to revenue/profit. This will just be the beginning of price controls.
There are ways around this, including our licensing molecules to entirely companies in the US. Rooting against your employer is dumb. If you hate the industry so much go someplace else.
There are ways around this, including out licensing molecules to entirely different companies in the US. Rooting against your employer is dumb. If you hate the industry so much go someplace else.
Don’t think your idea will work...at all. Prices will come down, of that there is no doubt. Don’t think anyone is rooting against the industry, but nobody can deny its greed. This will ripple through the industry causing layoffs.
C'mon people get real. Just take a look at Rexulti.It is NOT EVEN A ME TOO. It would be a me too if if was even as good as Abilify but it is not. It took 2 combined studies to get it thru for efficacy. It is no safer than anything else on the market. OK so if it isn't as good or isn't any safer, why is it priced higher? These types of decisions will end whether the company decides or the government decides for them.
Here comes the bill that will change the pharma industry forever, H.R. 3. It will save Americans hundreds of millions of dollars. It will also benefit seniors as well. Me-too drugs like we sell will find it hard going to compete. Companies that can’t innovate and discover real meaningful drugs will be in a world or hurt. Change in this industry is long overdue. If you can’t reinvent yourself, you will find yourself in a bad position if you want to stay in pharma.
Also: Failed bipolar studies from what I've read. But yes, a me-too, and a very expensive one on top of that!!
It was announced that we are not seeking a bipolar indication for Rexulti. Also, Takeda was told at their meeting that they would not seek any further indications for Trintellix. You have what you have until they go off patent.
Rexulti: no bipolar, no PTSD, no better than generic Abilify, no remission data, not much coverage. Again Glover, why should a doctor use a way too expensive me too called Rexulti??